1-4 of 4
Christophe Le Clorennec
Close
Sort by
Journal Articles

EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-κB, STAT1, and p53

Christophe Le Clorennec, Ibtissam Youlyouz-Marfak, Eric Adriaenssens, Jean Coll, Georg W. Bornkamm, Jean Feuillard
Journal: Blood
Blood (2006) 107 (5): 2070–2078.
https://doi.org/10.1182/blood-2005-05-2053
Published: 2006
Journal Articles

Antitumor Genotoxic Agents, Such as Fludarabine*, Doxorubincin or Cis-Platine, Induce Activation of STAT1 in a p53 Protein Dependent Manner.

Ibtissam Youlyouz-Marfak, Christophe Le Clorennec, Imen Najjar, Fanny Baran-Marszak, MD-PhD, Nathalie Gachard, MD, Liliane Remenieras, MD, Arnaud Jaccard, MD, Georg W. Bornkamm, Remi Fagard, Jean Feuillard
Journal: Blood
Blood (2005) 106 (11): 4384.
https://doi.org/10.1182/blood.V106.11.4384.4384
Published: 2005
Journal Articles

Regulation of CD95 in EBV infected B-Cells.

Christophe Le Clorennec, PhD, Ibtissam Youlyouz-Marfak, PhD, Eric Adriaenssens, PhD, Jean Coll, Dominique Bordessoule, Georg W. Bornkamm, Jean Feuillard
Journal: Blood
Blood (2004) 104 (11): 81.
https://doi.org/10.1182/blood.V104.11.81.81
Published: 2004
Journal Articles

Differential roles of STAT1α and STAT1β in fludarabine-induced cell cycle arrest and apoptosis in human B cells

Fanny Baran-Marszak, Jean Feuillard, Imen Najjar, Christophe Le Clorennec, Jean-Marie Béchet, Isabelle Dusanter-Fourt, Georg W. Bornkamm, Martine Raphaël, Remi Fagard
Journal: Blood
Blood (2004) 104 (8): 2475–2483.
https://doi.org/10.1182/blood-2003-10-3508
Published: 2004